In the US prescription drug costs are rising faster than any other component of health care expenditures, and show no signs of slowing. Factors driving the rise in prescription drug costs include the introduction of new drugs, and consumer demand. (*Title Incorrect in STL Original--check--change link name)
US FDA Advisory Committee Meetings Held to Discuss Isotretinoin, Safety Issues and a New Accutane Formulation
There is no drug that has provided as much therapeutic benefit for 12 million acne patients as this retinoid has done in the past 18 years following its introduction. However, it is a retinoid and, therefore, a teratogen.